ArticleCureus2025
Cardiac Involvement in a Lymphoma: A Rare Extranodal Site.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiac involvement in lymphoma is rare and usually presents as a late manifestation of the disease. Although clinically asymptomatic and mostly found on autopsy, some patients may present with ventricular outflow obstruction, valve dysfunction, arrhythmias, pericardial effusion, cardiac tamponade, and tumor embolization. Multimodality imaging is important in distinguishing cardiac masses to provide optimal treatment. Here, we describe the case of a 54-year-old woman who presented with dyspnea on exertion and hemodynamic compromise. With the aid of multimodality imaging, the patient was found to have a right atrial cardiac mass. Given her worsening symptoms and hemodynamic instability, the patient underwent excision of the right atrial mass. Ultimately, histopathology revealed diffuse large B-cell lymphoma. The patient was evaluated further and completed systemic therapy without any adverse events and achieved complete metabolic response (Deauville score 1). The patient completed her first-year follow-up, and an annual positron emission tomography-computed tomography showed no evidence of disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.